Ropinirole (Requip), rotigotine (Neupro) and pramipexole (Mirapex) are approved by the Food and Drug Administration for the treatment of moderate to severe RLS/WED. Short-term side effects of these medications are usually mild and include nausea, lightheadedness and fatigue.